Daily intraperitoneal injection of orexin-A (1 μmol/kg) at day 0 in mice xenografted with AsPC-1 cells and up to the mice sacrifices resulted in a significant decrease in tumor volume (48.8%), as compared to untreated mice (Figure 6A). The gene discussed is HCRT; the disease is neoplasm.